- ETST issues new audio press release regarding its audits, Form 10, financing plans and fully reporting status
- ETST has started 2017 fiscal year audit, which is required, along with the approved Form 10, to uplist to the OTCQB Venture Market
- Biotech company is focused on developing medical devices for the pharmaceutical and nutraceutical fields and marketing its high-grade line of hemp cannabidiol (CBD)
Earth Science Tech, Inc. (OTC: ETST) recently released an audio press release discussing its future financial plans and its previously announced completion of audits and Form 10 submission, which could lead to an uplisting to the OTCQB Venture Market (http://ibn.fm/JEWaC).
ETST has completed its audit for FY2015 and FY2016 and submitted its Form 10 to be fully reporting (http://ibn.fm/HDpTq), and it is currently conducting its audit for FY2017. That audit and the approved Form 10 submission, together, are needed for an uplisting to the OTCQB Venture Market.
ETST, a biotech company based in Doral, Florida, has repositioned its line of full-spectrum cannabidiol products. It also conducts R&D for low cost, non-invasive medical devices, as it concentrates on manufacturing, marketing and distributing its cannabinoid products to the nutraceutical and pharmaceutical markets.
Dr. Michel Aube, CEO and chief science officer of ETST, said that transparency is a key tool in the expansion of the company’s business and maintaining the confidence of investors. In a news release, he added, “Since all of our amazing projects are ongoing with our partners, investor confidence will grow, and we will be able to complete our first big round of financing.”
Nickolas Tabraue, director and president of ETST, said, “Thanks to our passionate, likeminded team, the transition should be smooth as we continue growing. I look forward to sharing updates on the full reporting process as it progresses.”
ETST holds four wholly owned subsidiaries. Cannabis Therapeutics is an emerging biotechnology company. KannaBidioiD manufactures and distributes in the recreational sector. Earth Science Foundation, Inc. is becoming a non-profit to accept grants and donations for conducting additional studies. Earth Science Pharmaceutical develops medical diagnostic tools and vaccines.
For more information, visit the company’s website at www.EarthScienceTech.com
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
